REFERENCES
- Molina JM, Marcelin AG, Pavie J, et al, A1454-176 JAGUAR Study Team. Didanosine in HIV-1-infected patients experiencing failure of antiretroviral therapy: a randomized placebo-controlled trial. J Infect Dis. 2005;191(6):840–847.
- Moreno S, Hernandez B, Dronda F. Didanosine enteric-coated capsule: current role in patients with HIV-1 infection. Drugs. 2007;67(10):1441–1462.
- Masié M, Gutiérrez F, Padilla S, Ramos JM, Pascual J. Severe toxicity associated with the combination of tenofovir and didanosine: case report and review. Int J STD AIDS. 2005;16(9):646–648.
- Saitoh A, Fenton T, Alvero C, Fletcher CV, Spector SA. Impact of nucleoside reverse transcriptase inhibi-tors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy. Antimicrob Agents Chemother. 2007;51(12):4236–4242.